Founded in 2001, Gentris Corporation is a globally operating provider of applied pharmacogenomic (PGx) services. Based in Morrisville, North Carolina, the company supports pharmaceutical companies and clinical research organizations to effectively integrate PGx into their clinical drug development programs. It offers single nucleotide polymorphism (SNP) genotyping, custom assay design/ validation, expression analysis and sample bio-storage. Some of the additional services offered by the company are bioinformatics sample logistics, neucleic acid isolation, micro array services, gene expression analysis and tumor profiling. Gentris Corporation is registered under Clinical Laboratory Improvement Amendments (CLIA) and its services are compliant with good laboratory practices (GLP) guidelines.